Cardiac tumors primary prevention

Cardiac tumors Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cardiac Tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cardiac tumors primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cardiac tumors primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cardiac tumors primary prevention
CDC on Cardiac tumors primary prevention
Cardiac tumors primary prevention in the news
Blogs on Cardiac tumors primary prevention
Directions to Hospitals Treating Cardiac tumors
Risk calculators and risk factors for Cardiac tumors primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dheeraj Makkar, M.D.[2]

Overview

Presently, primary prevention of cardiac tumors is not possible due to the lack of suitable techniques.

Primary Prevention

Definition: According to Wonca (World Organization of Family Doctors), Primary prevention involves interventions directed toward a vulnerable demographic or individual. Primary prevention is meant to keep a disease from ever arising. Therefore, its intended target consists of healthy people.

• There are no effective strategies for the primary prevention of cardiac tumors.
• The primary prevention is helpful in to reduce the development of heart problems after initiating Anthracyclines and radiation exposure for the treatment of cardiac malignancies. Some strategies are:
  • The use of protons (instead of photons) offers the possibility of preserving the proper dose to the size of the tumor while decreasing the dose administered to neighboring normal tissue.
  • Use of alternate anthracycline preparations, such as liposomal versions.
  • Lifestyle Changes